Alpha Biopharma Revenue and Competitors

Shanghai,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Alpha Biopharma's estimated annual revenue is currently $1.6M per year.(i)
  • Alpha Biopharma's estimated revenue per employee is $201,000

Employee Data

  • Alpha Biopharma has 8 Employees.(i)
  • Alpha Biopharma grew their employee count by 0% last year.

Alpha Biopharma's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Alpha Biopharma?

Alpha Biopharma – Specialized in drug innovation from clinical development to commercialization success. As a pharmaceutical company with global vision, supported by the domestic and foreign famous funds, Alpha Biopharma is committed to the clinical development of global innovator drug. With highly integrated team in Medical, Clinical Operation, Regulatory and Commercialization, Alpha Biopharma establishes strategic partnership with leading international pharmaceutical company/R&D institute.

keywords:N/A

N/A

Total Funding

8

Number of Employees

$1.6M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Alpha Biopharma News

2022-04-20 - AbbVie Walks Away From Alpha-synuclein Collaboration With BioArctic

(RTTNews) - AbbVie (ABBV) has terminated its collaboration with BioArctic AB, a Swedish biopharma company, to develop alpha-synuclein...

2022-04-20 - AbbVie ends research alliance on BioArctic Parkinson's drug

AbbVie's trimmed its Parkinson's disease research elsewhere, too, having ended another alpha synuclein-focused partnership with Voyager...

2022-04-20 - AbbVie shreds alpha- synuclein Parkinson's pact on cusp of ...

Unlearn works with biopharma companies to take historical patient data and create a “digital twin” before predicting the course of their disease...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A80%N/A
#2
$0.3M8N/AN/A
#3
N/A80%N/A
#4
$0.7M9N/AN/A
#5
$0.7M9-10%N/A